genetic disorders Apr 27, 2020 Illumina Loses Appeal for Injunction Against Ariosa Diagnostics, but Court Upholds $27M Judgment Apr 13, 2020 Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering Mar 17, 2020 US Appeals Court Overturns Roche Win in Illumina NIPT Suit Dec 11, 2019 Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing Premium Nov 8, 2019 Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains Premium Sep 16, 2019 Fulgent Genetics Taps PWNHealth to Oversee New Tests Marketed to Consumers Sep 13, 2019 Natera Finds High Performance for Noninvasive Prenatal Test in All Age Groups Premium Jul 10, 2019 NIPD Genetics Enters Cancer Dx Market, Expands Prenatal Testing Premium Apr 24, 2019 Rady Team Automates Rapid Pediatric Sequence Interpretation for Rare Disease Dx Apr 23, 2019 Illumina, Chinese Children's Hospital to Launch Newborn Sequencing Study Oct 9, 2018 Fulgent Genetics, StemCyte Partner on Genetic Testing Apr 26, 2018 Rainbow Genomics, UCLA Partner to Offer Exome Dx in Asia Apr 5, 2018 Rady Team Demos Improved Outcomes, Cost Savings of Rapid Whole Genome Sequencing in NICU Mar 12, 2018 Natera, Qiagen Partner to Develop Cell-Free DNA Assays for Prenatal Screening Dec 15, 2017 Exome Sequencing of Parents Uncovers Cause of Lethal Fetal Genetic Diseases Premium Oct 30, 2017 Arcedi Biotech Readying Cell-Based NIPT for Commercialization as Clinical Studies Continue Premium Sep 26, 2017 Baylor and Rainbow Genomics Partner to Offer Exome Sequencing in Asia Dec 14, 2016 Noninvasive Prenatal Single-Gene Disease Testing to Benefit from Universal Method Premium Breaking News Elevated Antibody Levels Identified in Patients With Severe Chronic Fatigue Syndrome In Brief This Week: Exact Sciences, Hologic, T2 Biosystems, Agilent, More Biosynex Files Takeover Bid to Buy Theradiag Congress to Pass FDA User Fee Bill Without VALID Act, Again Putting Aside LDT Regulation Bionano Genomics Launches CLIA-Certified Laboratory, First OGM-Based Test Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform
